BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 22201588)

  • 1. Nanocarriers for the simultaneous co-delivery of therapeutic genes and anticancer drugs.
    Choudhury NN; He H
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1317-31. PubMed ID: 22201588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug and gene co-delivery systems for cancer treatment.
    Yang Z; Gao D; Cao Z; Zhang C; Cheng D; Liu J; Shuai X
    Biomater Sci; 2015 Jul; 3(7):1035-49. PubMed ID: 26221938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selenium nanoparticles: potential in cancer gene and drug delivery.
    Maiyo F; Singh M
    Nanomedicine (Lond); 2017 May; 12(9):1075-1089. PubMed ID: 28440710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiol redox-sensitive cationic polymers for dual delivery of drug and gene.
    Syamala PS; Ramesan RM
    Ther Deliv; 2018 Oct; 9(10):751-773. PubMed ID: 30277132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-delivery strategies based on multifunctional nanocarriers for cancer therapy.
    Chen H; Zhao Y; Wang H; Nie G; Nan K
    Curr Drug Metab; 2012 Oct; 13(8):1087-96. PubMed ID: 22380013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
    Luo C; Sun J; Sun B; He Z
    Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research progress in co-delivery of gene and chemotherapy drugs with nanocarriers for cancer therapy].
    Chen WG; Wang SB
    Yao Xue Xue Bao; 2013 Jul; 48(7):1091-8. PubMed ID: 24133974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-targeting glycol chitosan nanocarriers: overcoming the challenges posed by chemotherapeutics.
    Choi Y; Lim S; Yoon HY; Kim BS; Kwon IC; Kim K
    Expert Opin Drug Deliv; 2019 Aug; 16(8):835-846. PubMed ID: 31343904
    [No Abstract]   [Full Text] [Related]  

  • 9. Co-delivery of drugs and plasmid DNA for cancer therapy.
    Teo PY; Cheng W; Hedrick JL; Yang YY
    Adv Drug Deliv Rev; 2016 Mar; 98():41-63. PubMed ID: 26529199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantum rods as nanocarriers of gene therapy.
    Aalinkeel R; Nair B; Reynolds JL; Sykes DE; Law WC; Mahajan SD; Prasad PN; Schwartz SA
    Drug Deliv; 2012 May; 19(4):220-31. PubMed ID: 22643056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in delivery of drug-nucleic acid combinations for cancer treatment.
    Li J; Wang Y; Zhu Y; Oupický D
    J Control Release; 2013 Dec; 172(2):589-600. PubMed ID: 23624358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active targeting strategies for anticancer drug nanocarriers.
    Basile L; Pignatello R; Passirani C
    Curr Drug Deliv; 2012 May; 9(3):255-68. PubMed ID: 22452402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zein-based Nanocarriers as Potential Natural Alternatives for Drug and Gene Delivery: Focus on Cancer Therapy.
    Elzoghby A; Freag M; Mamdouh H; Elkhodairy K
    Curr Pharm Des; 2017; 23(35):5261-5271. PubMed ID: 28641543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment.
    Afsharzadeh M; Hashemi M; Mokhtarzadeh A; Abnous K; Ramezani M
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1095-1110. PubMed ID: 28954547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanocarriers to solid tumors: considerations on tumor penetration and exposure of tumor cells to therapeutic agents.
    Bhagat M; Halligan S; Sofou S
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1306-16. PubMed ID: 22201591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ligand nanoparticle conjugation approach for targeted cancer therapy.
    Karra N; Benita S
    Curr Drug Metab; 2012 Jan; 13(1):22-41. PubMed ID: 21892918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of prodrug-based nano-drug delivery strategy in cancer combination therapy.
    Ge Y; Ma Y; Li L
    Colloids Surf B Biointerfaces; 2016 Oct; 146():482-9. PubMed ID: 27400243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel 'Stereoscopic Response' Strategy Can Be Used in Combination Therapy.
    Gu Z; Shaikh AS; Lin G
    Crit Rev Ther Drug Carrier Syst; 2018; 35(4):369-390. PubMed ID: 29972682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomes a vesicular nanocarrier: potential advancements in cancer chemotherapy.
    Kumar P; Gulbake A; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2012; 29(5):355-419. PubMed ID: 22876808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smart Drug Delivery Systems in Cancer Therapy.
    Unsoy G; Gunduz U
    Curr Drug Targets; 2018 Feb; 19(3):202-212. PubMed ID: 27033191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.